‘Rplate’™ – rapid antibiotic susceptibility test
A rapid, low cost, antibiotic susceptibility test for urinary tract infections
• Rapid time to result (TTR) (< 30m)
• Mass-manufacturable, platform
• High sensitivity and repeatability
• Affordable price
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial stewardship
- Microbial diagnostics
- Infection prevention
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Viruses
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Research
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- Co-develop
- License
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- BSI
- RTI
- STI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Global commercilisation partner – large/medium-sized IVD company to negotiate a deal where our partner would be responsible for sales, marketing, technical support and regulatory approval in the agreed territory, whether global or regional
Spinout company from the University of Strathclyde, Glasgow, UK
In time, we will expand the product platform to tackle not only UTIs, but other infections including systemic sepsis, respiratory tract infections, meningitis and systemic fungal infections etc
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!